CD4 and cancer: Furthermore, phenotypic and functional characterization of chemoradiotherapy‐induced IL‐17‐producing CD4+ T cells in the blood of larger patients cohorts would be of great interest to clarify the mechanisms responsible for Th17 resistance toward chemoradiotherapy and Th17‐based correlation with cancer relapse.